Who Owns RGC?

Regencell Bioscience Holdings Limited — Institutional Ownership & 13F Holdings

$29.30

+0.08 (+0.29%)

Market Cap

$14.3B

Shares Outstanding

494,488,908

Institutional Holders

5

Total Inst. Value

$281K

% of Float Held

0.1%

QoQ Holder Change

+1

Institutional data as of Q1 2025

New Positions

3

Closed Positions

2

Increased

1

Decreased

1

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1GEODE CAPITAL MANAGEMENT, LLCNew$217K6,816
2ROYAL BANK OF CANADANew$30K948
3Tower Research Capital LLC (TRC)New$22K698
4BlackRock, Inc.$12K363
5MORGAN STANLEY$05

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue
MORGAN STANLEY-2K$0

Related Stocks

Frequently Asked Questions

How many institutional investors hold RGC?

As of Q1 2025, 5 institutional investors report holding RGC (Regencell Bioscience Holdings Limited) in their 13F filings.

What percentage of Regencell Bioscience Holdings Limited is owned by institutions?

Institutional investors hold approximately 0.1% of Regencell Bioscience Holdings Limited's float as reported in SEC 13F filings.

Which hedge fund owns the most RGC?

The largest institutional holder of RGC is GEODE CAPITAL MANAGEMENT, LLC with $217K in shares.

Are institutions buying or selling RGC?

This quarter, 3 institutions opened new positions in RGC and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.